LCTX · Categories · Form 3

LCTX - SEC Form 3 initial insider statements

Lineage Cell Therapeutics Inc. (LCTX) sec form 3 initial insider statements - real-time wire coverage filtered to Form 3 only.

Recent Form 3 for LCTX

• 1301d
  SEC Form 3 filed by new insider Howe Jill Ann

  3 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
• 1432d
  SEC Form 3 filed by new insider Hernandez Alexandra

  3 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
• 1741d
  SEC Form 3 filed by new insider Samuel George A. Iii

  3 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
• 1804d
  SEC Form 3 filed by Lineage Cell Therapeutics, Inc.

  3 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
• 1860d
  SEC Form 3 filed by Jayasuriya Anula

  3 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
• 1874d
  SEC Form 3 filed by Amin Dipti

  3 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)
• 1964d
  SEC Form 3 filed by Alexandra Hernandez

  3 - Lineage Cell Therapeutics, Inc. (0000876343) (Issuer)

Other LCTX categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 4
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends